Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, Y.
Right arrow Articles by Ip, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, Y.
Right arrow Articles by Ip, C.
[Cancer Research 61, 2923-2928, April 1, 2001]
© 2001 American Association for Cancer Research


Epidemiology and Prevention

Characterization of the Biological Activity of {gamma}-Glutamyl-Se- methylselenocysteine

A Novel, Naturally Occurring Anticancer Agent from Garlic1

Yan Dong, Donald Lisk, Eric Block and Clement Ip2

Department of Experimental Pathology, Roswell Park Cancer Institute, Buffalo, New York 14263 [Y. D., C. I.]; Department of Fruit and Vegetable Science, Cornell University, Ithaca, New York 14853 [D. L.]; and Department of Chemistry, State University of New York at Albany, Albany, New York 12222 [E. B.]

{gamma}-Glutamyl-Se-methylselenocysteine (GGMSC) has recently been identified as the major Se compound in natural garlic and selenized garlic. Our working hypothesis is that GGMSC serves primarily as a carrier of Se-methylselenocysteine (MSC), which has been demonstrated in past research to be a potent cancer chemopreventive agent in animal carcinogenesis bioassays. The present study was designed to examine the in vivo responses to GGMSC or MSC using a variety of biochemical and biological end points, including (a) urinary Se excretion as a function of bolus dose; (b) tissue Se accumulation profile; (c) anticancer efficacy; and (d) gene expression changes as determined by cDNA array analysis. Our results showed that like MSC, GGMSC was well absorbed p.o., with urinary excretion as the major route for eliminating excess Se. When fed chronically, the profile of Se accumulation in various tissues was very comparable after treatment with either GGMSC or MSC. In rats that had been challenged with a carcinogen, supplementation with either GGMSC or MSC resulted in a lower prevalence of premalignant lesions in the mammary gland, and fewer mammary carcinomas when these early lesions were allowed to progress. More importantly, we found that a short term GGMSC/MSC treatment schedule of 4 weeks immediately after carcinogen dosing was sufficient to provide significant cancer protection, even in the absence of a sustained exposure past the initial 4-week period. With the use of the Clontech Atlas Rat cDNA Array, we further discovered that the gene expression changes induced in mammary epithelial cells of rats that were given either GGMSC or MSC showed a high degree of concordance. On the basis of the collective biology, biochemistry, and molecular biology data, we conclude that GGMSC is an effective anticancer agent with a mechanism of action very similar to that of MSC.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
J.-I. Lee, H. Nian, A. J.L. Cooper, R. Sinha, J. Dai, W. H. Bisson, R. H. Dashwood, and J. T. Pinto
{alpha}-Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells
Cancer Prevention Research, July 1, 2009; 2(7): 683 - 693.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
X. Zhang and H. Zarbl
Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue
Cancer Prevention Research, July 1, 2008; 1(2): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Milner
Preclinical Perspectives on Garlic and Cancer
J. Nutr., March 1, 2006; 136(3): 827S - 831S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Tsuneyoshi, J. Yoshida, and T. Sasaoka
Hydroponic Cultivation Offers A Practical Means of Producing Selenium-Enriched Garlic
J. Nutr., March 1, 2006; 136(3): 870S - 872S.
[Abstract] [Full Text] [PDF]


Home page
ANN BOT (LOND)Home page
J. W. FINLEY
Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds
Ann. Bot., June 1, 2005; 95(7): 1075 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Filomeni, K. Aquilano, G. Rotilio, and M. R. Ciriolo
Reactive Oxygen Species-dependent c-Jun NH2-terminal Kinase/c-Jun Signaling Cascade Mediates Neuroblastoma Cell Death Induced by Diallyl Disulfide
Cancer Res., September 15, 2003; 63(18): 5940 - 5949.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
P. D. Whanger
Selenocompounds in Plants and Animals and their Biological Significance
J. Am. Coll. Nutr., June 1, 2002; 21(3): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Dong, H. E. Ganther, C. Stewart, and C. Ip
Identification of Molecular Targets Associated with Selenium-induced Growth Inhibition in Human Breast Cells Using cDNA Microarrays
Cancer Res., February 1, 2002; 62(3): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Zhu, W. Jiang, H. E. Ganther, and H. J. Thompson
Mechanisms of Cell Cycle Arrest by Methylseleninic Acid
Cancer Res., January 1, 2002; 62(1): 156 - 164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.